Phase I clinical and pharmacokinetic study of high-dose mitoxantrone combined with carboplatin, cyclophosphamide, and autologous bone marrow rescue: high response rate for refractory ovarian carcinoma.

Stiff PJ, McKenzie RS, Alberts DS, Sosman JA, Dolan JR, Rad N, McCloskey T
J Clin Oncol. 1994 12 (1): 176-83

PMID: 8270975 · DOI:10.1200/JCO.1994.12.1.176

MeSH Terms (14)

Adult Antineoplastic Combined Chemotherapy Protocols Bone Marrow Diseases Bone Marrow Transplantation Carboplatin Cyclophosphamide Female Humans Male Middle Aged Mitoxantrone Neoplasms Ovarian Neoplasms Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities: